The Senate last night voted 98-2 to approve the Patient Right to Know Drug Prices Act (S. 2554), a bill that would prohibit private health plans from restricting a pharmacist’s ability to inform enrollees when a drug would cost less without using their insurance. Some health insurance contracts prevent pharmacists from informing patients when the cash price for their prescription costs less than their insurance cost-sharing arrangement unless the individual asks. The Senate earlier this month passed a similar bill that applies to patients in Medicare Advantage and Medicare Part D plans. The House Energy and Commerce Committee last week approved similar legislation for Medicare and private health plans.

Related News Articles

Headline
Kansas Gov. Laura Kelly has reached agreement with Senate Republicans on a bipartisan proposal to expand Medicaid eligibility to low-income uninsured…
Headline
The Centers for Medicare & Medicaid Services has delayed 2020 private payer data reporting for the Clinical Diagnostic Test Payment System until 2021 for…
Headline
The Senate today voted 71-23 to pass legislation (H.R. 1865) funding the Department of Health and Human Services and other non-Defense agencies for fiscal…
Headline
The House today approved a $1.4 trillion spending package for fiscal year 2020. The bills include a number of key issues for hospitals and health systems…
Headline
Leaders of the House and Senate Appropriations committees have reached an agreement in principle on fiscal year 2020 funding, with the House expected to vote…
Headline
AHA and its American Organization for Nursing Leadership today voiced support for the Resolving Extended Limbo for Immigrant Employees and Families Act (S.…